Johnson & Johnson
JNJFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/29/2024
Revenue
88,821
Cost of Revenue
27,471
Gross Profit
61,350
Gross Margin
69.1%
Operating Income
22,149
Operating Margin
24.9%
Net Income
14,066
Net Margin
15.8%
EPS (Basic)
$5.84
EPS (Diluted)
$5.79
EBITDA
24,781
EBITDA Margin
27.9%
2023
12/31/2023
Revenue
85,159
Cost of Revenue
26,553
Gross Profit
58,606
Gross Margin
68.8%
Operating Income
23,409
Operating Margin
27.5%
Net Income
35,153
Net Margin
41.3%
EPS (Basic)
$13.88
EPS (Diluted)
$13.72
EBITDA
23,320
EBITDA Margin
27.4%
2022
12/31/2022
Revenue
79,990
Cost of Revenue
24,596
Gross Profit
55,394
Gross Margin
69.3%
Operating Income
21,013
Operating Margin
26.3%
Net Income
17,941
Net Margin
22.4%
EPS (Basic)
$6.83
EPS (Diluted)
$6.73
EBITDA
26,605
EBITDA Margin
33.3%
2021
12/31/2021
Revenue
78,740
Cost of Revenue
23,402
Gross Profit
55,338
Gross Margin
70.3%
Operating Income
20,943
Operating Margin
26.6%
Net Income
20,878
Net Margin
26.5%
EPS (Basic)
$7.93
EPS (Diluted)
$7.81
EBITDA
26,751
EBITDA Margin
34.0%
2020
12/31/2020
Revenue
82,584
Cost of Revenue
28,427
Gross Profit
54,157
Gross Margin
65.6%
Operating Income
19,733
Operating Margin
23.9%
Net Income
14,714
Net Margin
17.8%
EPS (Basic)
$5.59
EPS (Diluted)
$5.51
EBITDA
23,929
EBITDA Margin
29.0%